Abstract
Purpose
To determine the risk factors related to recurrence of pterygium after pterygium excision with limbal-conjunctival autograft.
Study design
Retrospective, observational case series.
Methods
The current study included 310 patients who underwent surgical removal of pterygium using limbal-conjunctival autografting. All surgery was performed by the same surgeon at a single Hospital from 2006 to 2011. Preoperative and postoperative patient data were collected. The patients were summoned to follow-up examinations. Procedures with at least 12 months of follow-up were included in the final analysis. Potential risk factors for pterygium recurrence were determined by Cox proportional-hazard linear analysis and recurrence-free survival time was evaluated using Kaplan–Meier method.
Results
The overall recurrence rate was 5.2% during an average follow-up time of 20.1±8.6 months (range, 12–37 months). According to Kaplan–Meier evaluation, the estimated time to recurrence was 34.2 ± 0.5 months (95% confidence interval 33.3–35.0 months) for the whole population. Multivariate analysis showed that age < 45 years old (RR = 3.582, 95% CI 1.984–13.044, P = 0.047), recurrent type of pterygia (RR = 4.856, 95% CI 1.794–13.142, P = 0.002), and vertical size of pterygium > 6.7 mm (RR = 2.529, 95% CI 1.053–6.075, P = 0.038) were significantly associated with increased risk of recurrence.
Conclusion
Our findings suggest that young age, recurrent type of pterygia, and larger pterygial tissue are risk factors for pterygium recurrence after surgical excision. Hence, early excision of pterygium is recommended to decrease the recurrence rate.
Similar content being viewed by others
References
Saw SM, Tan D. Pterygium: prevalence, demography and risk factors. Ophthalmic Epidemiol. 1999;6:219–28.
Gulani A, Dastur YK. Simultaneous pterygium and cataract surgery. J Postgrad Med. 1995;41:8–11.
Wu K, He M, Xu J, Li S. Pterygium in aged population in Doumen County, China. Yan Ke Xue Bao. 2002;18:181–4.
Fotouhi A, Hashemi H, Khabazkhoob M, Mohammad K. Prevalence and risk factors of pterygium and pinguecula: the Tehran Eye Study. Eye (Lond). 2009;23:1125–9. https://doi.org/10.1038/eye.2008.200.
Verma N, Garap JA, Maris R, Kerek A. Intraoperative use of mitomycin C in the treatment of recurrent pterygium. P N G Med J. 1998;41:37–42.
Donnenfeld ED, Perry HD, Fromer S, Doshi S, Solomon R, Biser S. Subconjunctival mitomycin C as adjunctive therapy before pterygium excision. Ophthalmology. 2003;110:1012–6.
Viani GA, Fonseca EC, De Fendi LI, Rocha EM. Conjunctival autograft alone or combined with adjuvant beta-radiation? A randomized clinical trial. Int J Radiat Oncol Biol Phys. 2012;82:e507–11.
Yu C, Liang W, Huang Y, Guan W. Comparison of clinical efficacy of three surgical methods in the treatment of pterygium. Eye Sci. 2011;26:193–6.
Kenyon KR, Wagoner MD, Hettinger ME. Conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology. 1985;92:1461–70.
Ti SE, Chee SP, Dear KB, Tan DT. Analysis of variation in success rates in conjunctival autografting for primary and recurrent pterygium. Br J Ophthalmol. 2000;84:385–9.
Kaufman SC, Jacobs DS, Lee WB, Deng SX, Rosenblatt MI, Shtein RM. Options and adjuvants in surgery for pterygium: a report by the American Academy of Ophthalmology. Ophthalmology. 2013;120:201–8.
Tan DT, Chee SP, Dear KB, Lim AS. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol. 1997;115:1235–40.
Guler M, Sobaci G, Ilker S, Ozturk F, Mutlu FM, Yildirim E. Limbal-conjunctival autograft transplantation in cases with recurrent pterygium. Acta Ophthalmol (Copenh). 1994;72:721–6.
Sati A, Shankar S, Jha A, Kalra D, Mishra S, Gurunadh VS. Comparison of efficacy of three surgical methods of conjunctival autograft fixation in the treatment of pterygium. Int Ophthalmol. 2014;34:1233–9.
Ang LP, Chua JL, Tan DT. Current concepts and techniques in pterygium treatment. Curr Opin Ophthalmol. 2007;18:308–13.
Fernandes M, Sangwan VS, Bansal AK, Gangopadhyay N, Sridhar MS, Garg P, et al. Outcome of pterygium surgery: analysis over 14 years. Eye (Lond). 2005;19:1182–90.
Mahar PS, Manzar N. Pterygium recurrence related to its size and corneal involvement. J Coll Physicians Surg Pak. 2013;23:120–3.
Yaisawang S, Piyapattanakorn P. Role of post-operative topical corticosteroids in recurrence rate after pterygium excision with conjunctival autograft. J Med Assoc Thail. 2003;86(Suppl 2):S215–23.
Mutlu FM, Sobaci G, Tatar T, Yildirim E. A comparative study of recurrent pterygium surgery: limbal conjunctival autograft transplantation versus mitomycin C with conjunctival flap. Ophthalmology. 1999;106:817–21.
Avisar R, Arnon A, Avisar E, Weinberger D. Primary pterygium recurrence time. Isr Med Assoc J. 2001;3:836–7.
Varssano D, Shalev H, Lazar M, Fischer N. Pterygium excision with conjunctival autograft: true survival rate statistics. Cornea. 2013;32:1243–50.
Ha SW, Park JH, Shin IH, Kim HK. Clinical analysis of risk factors contributing to recurrence of pterygium after excision and graft surgery. Int J Ophthalmol. 2015;8:522–7.
Huerva V, March A, Martinez-Alonso M, Muniesa MJ, Sanchez C. Pterygium surgery by means of conjunctival autograft: long term follow-up. Arq Bras Oftalmol. 2012;75:251–5.
Kwon SH, Kim HK. Analysis of recurrence patterns following pterygium surgery with conjunctival autografts. Medicine (Baltimore). 2015;94:e518.
Olusanya BA, Ogun OA, Bekibele CO, Ashaye AO, Baiyeroju AM, Fasina O, et al. Risk factors for pterygium recurrence after surgical excision with combined conjunctival autograft (CAG) and intraoperative antimetabolite use. Afr J Med Sci. 2014;43:35–40.
Figueiredo RS, Cohen EJ, Gomes JA, Rapuano CJ, Laibson PR. Conjunctival autograft for pterygium surgery: how well does it prevent recurrence? Ophthalmic Surg Lasers. 1997;28:99–104.
Bradley JC, Yang W, Bradley RH, Reid TW, Schwab IR. The science of pterygia. Br J Ophthalmol. 2010;94:815–20.
Di Girolamo N, Wakefield D, Coroneo MT. UVB-mediated induction of cytokines and growth factors in pterygium epithelial cells involves cell surface receptors and intracellular signaling. Investig Ophthalmol Vis Sci. 2006;47:2430–7.
Kuo CH, Miyazaki D, Nawata N, Tominaga T, Yamasaki A, Sasaki Y, et al. Prognosis-determinant candidate genes identified by whole genome scanning in eyes with pterygia. Investig Ophthalmol Vis Sci. 2007;48:3566–75.
Detorakis E, Sourvinos G, Tsamparlakis J, Spandidos D. Evaluation of loss of heterozygosity and microsatellite instability in human pterygium: clinical correlations. Br J Ophthalmol. 1998;82(11):1324–8.
Bahar I, Kaiserman I, Weisbrod M, McAllum P, Slomovic A. Extensive versus limited pterygium excision with conjunctival autograft: outcomes and recurrence rates. Curr Eye Res. 2008;33:435–40.
Mahar P, Manzar N. Risk factors involved in pterygium recurrence after surgical excision. Pak J Ophthalmol. 2014;30:73.
Sarnicola V, Vannozzi L, Motolese PA. Recurrence rate using fibrin glue-assisted ipsilateral conjunctival autograft in pterygium surgery: 2-year follow-up. Cornea. 2010;29:1211–4.
Amano S, Motoyama Y, Oshika T, Eguchi S, Eguchi K. Comparative study of intraoperative mitomycin C and beta irradiation in pterygium surgery. Br J Ophthalmol. 2000;84:618–21.
Yamada T, Mochizuki H, Ue T, Kiuchi Y, Takahashi Y, Oinaka M. Comparative study of different beta-radiation doses for preventing pterygium recurrence. Int J Radiat Oncol Biol Phys. 2011;81:1394–8.
Anguria P, Ntuli S, Carmichael T. Young patient’s age determines pterygium recurrence after surgery. Afr Health Sci. 2014;14:72–6.
Pavesio CE, Decory HH. Treatment of ocular inflammatory conditions with loteprednol etabonate. Br J Ophthalmol. 2008;92:455–9.
Altman DG, Royston P. The cost of dichotomising continuous variables. BMJ. 2006;332:1080. https://doi.org/10.1136/bmj.332.7549.1080.
Acknowledgements
The authors acknowledge all the participants of this study and nursing staff of the Imam Khomeini Hospital for their helping with data collection.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
N. S. Aidenloo, None; Q. Motarjemizadeh, None; M. Heidarpanah, None.
About this article
Cite this article
Aidenloo, N.S., Motarjemizadeh, Q. & Heidarpanah, M. Risk factors for pterygium recurrence after limbal-conjunctival autografting: a retrospective, single-centre investigation. Jpn J Ophthalmol 62, 349–356 (2018). https://doi.org/10.1007/s10384-018-0582-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10384-018-0582-9